Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.

Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page
- Check4 days agoChange DetectedNew help and navigation items were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment. The page revision indicator was updated from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference1%

- Check11 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This indicates a minor update to the page's metadata.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe footer revision tag updated from v3.5.3 to v3.5.4, signaling a new page build without changes to the displayed study content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, indicating a site release rather than a substantive change to the trial record.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision indicator updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.